Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0650
0.00 (0.00%)
Oct 26, 2026, 4:10 PM AEDT
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 23 million as of October 27, 2026. It is the 38,353rd most valuable company in the world and the 1,024th biggest in Australia. Its market cap has decreased by 24.18% in one year.
Market Cap
23.00M
Enterprise Value
19.81M
Revenue
1.74M
Global Rank
Country Rank
#1,024 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has decreased from 32.74M to 23.00M, a decrease of -29.75%. That is a compound annual growth rate of -3.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 23.00M | -47.75% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 542.19M |
| Healius | 315.88M |
| Monash IVF Group | 277.61M |
| Identifai Genetics | 71.99M |
| Cryosite | 59.55M |
| BCAL Diagnostics | 29.49M |
| Microba Life Sciences | 24.51M |
| INOVIQ | 19.71M |